AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Jun 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-06-12

Reporting Person: MCGLYNN MARGARET G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-12	Stock Options (right to buy)	$2.80	A	15000	Acquired	2024-06-12	Common Stock (15000)	Direct

Footnotes

F1: One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2015.